Download Full Text (200 KB)

Document Type



Bronchitis is one of the most common acute infections affecting pediatric patients. Most cases are caused by viral infections, do not respond to antibiotic therapy, and can take up to 14 days to resolve with supportive therapy. The purpose of this study is to determine if the use of Pelargonium Sidoides (Umcka™, EPs 7630) extract will decrease the duration and severity of symptoms from acute bronchitis in the pediatric population. Pelargonium Sidoides abstract is an extract of an African Geranium that has been used in traditional medicine for centuries. The review of the literature will evaluate multiple randomized controlled trials along with other studies that compare placebo, traditional supportive therapy and Pelargonium Sidoides extract to determine if the use of the extract will decrease severity and duration of illness without unacceptable side effects in the pediatric population. It has been demonstrated that providers will be able to safely advise patients to use Pelargonium Sidoides extract without any adverse side effects while helping to decrease the severity and duration of bronchitis symptoms in children. The finding indicate that routine use of Pelargonium Sidoides may give providers an alternative, effective and safe treatment that is well accepted by patients and caregivers for bronchitis in pediatric populations greater than one year of age compared to supportive therapy


Physician Assistant Studies

Degree Name

Master of Physician Assistant Studies (MPAS)

First Advisor

Susan Kuntz

Second Advisor

Vikki McCleary

Publication Date



Anti-Bacterial Agents -- therapeutic use; Bronchitis -- drug therapy; Child; Child, Preschool; Pelargonium; Phytotherapy; Plant Extracts -- therapeutic use; Treatment Outcome; Comparative Study


Respiratory Tract Diseases

Treatment of Acute Bronchitis in Children with Pelargonium Sidoides